nodes	percent_of_prediction	percent_of_DWPC	metapath
Spectinomycin—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.0335	0.0335	CcSEcCtD
Spectinomycin—Tenderness—Irbesartan—type 2 diabetes mellitus	0.0231	0.0231	CcSEcCtD
Spectinomycin—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.0196	0.0196	CcSEcCtD
Spectinomycin—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.0173	0.0173	CcSEcCtD
Spectinomycin—Chills—Glipizide—type 2 diabetes mellitus	0.0166	0.0166	CcSEcCtD
Spectinomycin—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.0159	0.0159	CcSEcCtD
Spectinomycin—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.0158	0.0158	CcSEcCtD
Spectinomycin—Urticaria—Tolazamide—type 2 diabetes mellitus	0.0158	0.0158	CcSEcCtD
Spectinomycin—Urticaria—Linagliptin—type 2 diabetes mellitus	0.0156	0.0156	CcSEcCtD
Spectinomycin—Urticaria—Acarbose—type 2 diabetes mellitus	0.0152	0.0152	CcSEcCtD
Spectinomycin—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.015	0.015	CcSEcCtD
Spectinomycin—Urticaria—Nateglinide—type 2 diabetes mellitus	0.0146	0.0146	CcSEcCtD
Spectinomycin—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.0145	0.0145	CcSEcCtD
Spectinomycin—Nausea—Miglitol—type 2 diabetes mellitus	0.0144	0.0144	CcSEcCtD
Spectinomycin—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.0141	0.0141	CcSEcCtD
Spectinomycin—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.0136	0.0136	CcSEcCtD
Spectinomycin—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.0131	0.0131	CcSEcCtD
Spectinomycin—Dizziness—Tolazamide—type 2 diabetes mellitus	0.0131	0.0131	CcSEcCtD
Spectinomycin—Nausea—Tolbutamide—type 2 diabetes mellitus	0.013	0.013	CcSEcCtD
Spectinomycin—Urticaria—Repaglinide—type 2 diabetes mellitus	0.0126	0.0126	CcSEcCtD
Spectinomycin—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.0126	0.0126	CcSEcCtD
Spectinomycin—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.0123	0.0123	CcSEcCtD
Spectinomycin—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.0123	0.0123	CcSEcCtD
Spectinomycin—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.0122	0.0122	CcSEcCtD
Spectinomycin—Dizziness—Nateglinide—type 2 diabetes mellitus	0.0122	0.0122	CcSEcCtD
Spectinomycin—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.012	0.012	CcSEcCtD
Spectinomycin—Insomnia—Glipizide—type 2 diabetes mellitus	0.0119	0.0119	CcSEcCtD
Spectinomycin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.0118	0.0118	CcSEcCtD
Spectinomycin—Nausea—Tolazamide—type 2 diabetes mellitus	0.0118	0.0118	CcSEcCtD
Spectinomycin—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.0117	0.0117	CcSEcCtD
Spectinomycin—Chills—Gliclazide—type 2 diabetes mellitus	0.0115	0.0115	CcSEcCtD
Spectinomycin—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.0114	0.0114	CcSEcCtD
Spectinomycin—Nausea—Acarbose—type 2 diabetes mellitus	0.0113	0.0113	CcSEcCtD
Spectinomycin—Insomnia—Glimepiride—type 2 diabetes mellitus	0.0111	0.0111	CcSEcCtD
Spectinomycin—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.0111	0.0111	CcSEcCtD
Spectinomycin—Nausea—Nateglinide—type 2 diabetes mellitus	0.0109	0.0109	CcSEcCtD
Spectinomycin—Urticaria—Glipizide—type 2 diabetes mellitus	0.0105	0.0105	CcSEcCtD
Spectinomycin—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.01	0.01	CcSEcCtD
Spectinomycin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.01	0.01	CcSEcCtD
Spectinomycin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00995	0.00995	CcSEcCtD
Spectinomycin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00976	0.00976	CcSEcCtD
Spectinomycin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00973	0.00973	CcSEcCtD
Spectinomycin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.0097	0.0097	CcSEcCtD
Spectinomycin—Chills—Metformin—type 2 diabetes mellitus	0.00962	0.00962	CcSEcCtD
Spectinomycin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00946	0.00946	CcSEcCtD
Spectinomycin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0093	0.0093	CcSEcCtD
Spectinomycin—Chills—Irbesartan—type 2 diabetes mellitus	0.00908	0.00908	CcSEcCtD
Spectinomycin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00906	0.00906	CcSEcCtD
Spectinomycin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00903	0.00903	CcSEcCtD
Spectinomycin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00894	0.00894	CcSEcCtD
Spectinomycin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00881	0.00881	CcSEcCtD
Spectinomycin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00877	0.00877	CcSEcCtD
Spectinomycin—Dizziness—Glipizide—type 2 diabetes mellitus	0.00871	0.00871	CcSEcCtD
Spectinomycin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00836	0.00836	CcSEcCtD
Spectinomycin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00834	0.00834	CcSEcCtD
Spectinomycin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00826	0.00826	CcSEcCtD
Spectinomycin—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00823	0.00823	CcSEcCtD
Spectinomycin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00813	0.00813	CcSEcCtD
Spectinomycin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.0081	0.0081	CcSEcCtD
Spectinomycin—Urticaria—Glyburide—type 2 diabetes mellitus	0.00805	0.00805	CcSEcCtD
Spectinomycin—Nausea—Glipizide—type 2 diabetes mellitus	0.00782	0.00782	CcSEcCtD
Spectinomycin—Insomnia—Valsartan—type 2 diabetes mellitus	0.00756	0.00756	CcSEcCtD
Spectinomycin—Insomnia—Orlistat—type 2 diabetes mellitus	0.00747	0.00747	CcSEcCtD
Spectinomycin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00747	0.00747	CcSEcCtD
Spectinomycin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00733	0.00733	CcSEcCtD
Spectinomycin—Nausea—Glimepiride—type 2 diabetes mellitus	0.0073	0.0073	CcSEcCtD
Spectinomycin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00728	0.00728	CcSEcCtD
Spectinomycin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00723	0.00723	CcSEcCtD
Spectinomycin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.0072	0.0072	CcSEcCtD
Spectinomycin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00719	0.00719	CcSEcCtD
Spectinomycin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00676	0.00676	CcSEcCtD
Spectinomycin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00671	0.00671	CcSEcCtD
Spectinomycin—Urticaria—Valsartan—type 2 diabetes mellitus	0.00664	0.00664	CcSEcCtD
Spectinomycin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00659	0.00659	CcSEcCtD
Spectinomycin—Urticaria—Orlistat—type 2 diabetes mellitus	0.00656	0.00656	CcSEcCtD
Spectinomycin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00653	0.00653	CcSEcCtD
Spectinomycin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00616	0.00616	CcSEcCtD
Spectinomycin—Insomnia—Losartan—type 2 diabetes mellitus	0.00612	0.00612	CcSEcCtD
Spectinomycin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00609	0.00609	CcSEcCtD
Spectinomycin—Urticaria—Metformin—type 2 diabetes mellitus	0.00605	0.00605	CcSEcCtD
Spectinomycin—Nausea—Glyburide—type 2 diabetes mellitus	0.00602	0.00602	CcSEcCtD
Spectinomycin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00602	0.00602	CcSEcCtD
Spectinomycin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.0058	0.0058	CcSEcCtD
Spectinomycin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00571	0.00571	CcSEcCtD
Spectinomycin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00568	0.00568	CcSEcCtD
Spectinomycin—Dizziness—Valsartan—type 2 diabetes mellitus	0.00553	0.00553	CcSEcCtD
Spectinomycin—Dizziness—Orlistat—type 2 diabetes mellitus	0.00546	0.00546	CcSEcCtD
Spectinomycin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00541	0.00541	CcSEcCtD
Spectinomycin—Urticaria—Losartan—type 2 diabetes mellitus	0.00537	0.00537	CcSEcCtD
Spectinomycin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00535	0.00535	CcSEcCtD
Spectinomycin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00529	0.00529	CcSEcCtD
Spectinomycin—Insomnia—Ramipril—type 2 diabetes mellitus	0.00525	0.00525	CcSEcCtD
Spectinomycin—Dizziness—Metformin—type 2 diabetes mellitus	0.00504	0.00504	CcSEcCtD
Spectinomycin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00498	0.00498	CcSEcCtD
Spectinomycin—Nausea—Valsartan—type 2 diabetes mellitus	0.00497	0.00497	CcSEcCtD
Spectinomycin—Nausea—Orlistat—type 2 diabetes mellitus	0.00491	0.00491	CcSEcCtD
Spectinomycin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00475	0.00475	CcSEcCtD
Spectinomycin—Urticaria—Ramipril—type 2 diabetes mellitus	0.00461	0.00461	CcSEcCtD
Spectinomycin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00458	0.00458	CcSEcCtD
Spectinomycin—Nausea—Metformin—type 2 diabetes mellitus	0.00452	0.00452	CcSEcCtD
Spectinomycin—Dizziness—Losartan—type 2 diabetes mellitus	0.00447	0.00447	CcSEcCtD
Spectinomycin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00427	0.00427	CcSEcCtD
Spectinomycin—Nausea—Irbesartan—type 2 diabetes mellitus	0.00427	0.00427	CcSEcCtD
Spectinomycin—Nausea—Losartan—type 2 diabetes mellitus	0.00402	0.00402	CcSEcCtD
Spectinomycin—Dizziness—Ramipril—type 2 diabetes mellitus	0.00383	0.00383	CcSEcCtD
Spectinomycin—Nausea—Ramipril—type 2 diabetes mellitus	0.00344	0.00344	CcSEcCtD
